Abadi Lestari Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Abadi Lestari Indonesia Tbk. trades at Rp3,730 (market cap 10.41T, 1.29M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. and Tempo Scan Pacific Tbk. are close in size by market cap, and Abadi Lestari Indonesia Tbk. is more actively traded (1.29M versus 429.7K). Which is the better fit depends on your goals.
| RLCO | TSPC | |
|---|---|---|
Market Cap | 10.41T | 11.68T |
Volume | 1.29M | 429.7K |
Lot | 12.9K | 4.3K |
Turnover | 4.67B | 1.11B |
Average Price | 3,617.04 | 2,591.65 |
Value | 4.67B | 1.11B |
Indicative Equilibrium Price | 3,730 | 2,580 |
Indicative Equilibrium Volume | 142 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →